X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (129) 129
Patent (16) 16
Conference Proceeding (10) 10
Book Review (6) 6
Publication (6) 6
Book / eBook (2) 2
Dissertation (2) 2
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (58) 58
humans (52) 52
oncology (45) 45
female (35) 35
male (34) 34
middle aged (29) 29
cancer (27) 27
adult (21) 21
aged (21) 21
hepatocellular carcinoma (20) 20
liver cancer (15) 15
chemotherapy (14) 14
animals (13) 13
treatment outcome (13) 13
accessories therefor (12) 12
fixed constructions (12) 12
handcuffs (12) 12
keys (12) 12
locks (12) 12
safes (12) 12
window or door fittings (12) 12
antineoplastic combined chemotherapy protocols - therapeutic use (11) 11
hepatoma (11) 11
liver neoplasms - drug therapy (11) 11
metastasis (11) 11
performing operations (11) 11
transporting (11) 11
tumors (11) 11
carcinoma, hepatocellular - drug therapy (10) 10
care and treatment (10) 10
gastroenterology & hepatology (10) 10
general tagging of cross-sectional technologies spanning over several sections of the ipc (10) 10
general tagging of new technological developments (10) 10
liver (10) 10
patients (10) 10
prognosis (10) 10
survival (10) 10
technical subjects covered by former us classification (10) 10
technical subjects covered by former uspc (10) 10
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (10) 10
analysis (9) 9
deoxycytidine - analogs & derivatives (9) 9
digestive system diseases (9) 9
research (9) 9
surgery (9) 9
therapy (9) 9
medicine (8) 8
medicine & public health (8) 8
mice (8) 8
removable external protective coverings specially adapted forvehicles (8) 8
vehicles in general (8) 8
windows, windscreens, non-fixed roofs, doors, or similardevices for vehicles (8) 8
aged, 80 and over (7) 7
capecitabine (7) 7
deoxycytidine - administration & dosage (7) 7
fluorouracil - administration & dosage (7) 7
liver neoplasms - pathology (7) 7
radiotherapy (7) 7
retrospective studies (7) 7
technical subjects covered by former uspc cross-reference artcollections [xracs] and digests (7) 7
angiogenesis (6) 6
antimitotic agents (6) 6
antineoplastic agents (6) 6
clinical trials (6) 6
colorectal cancer (6) 6
fluorouracil (6) 6
fluorouracil - analogs & derivatives (6) 6
gastric cancer (6) 6
management (6) 6
medical prognosis (6) 6
multidisciplinary sciences (6) 6
sorafenib (6) 6
studies (6) 6
time factors (6) 6
5-fluorouracil (5) 5
apoptosis (5) 5
cancer patients (5) 5
carcinoma (5) 5
carcinoma, hepatocellular - pathology (5) 5
cells (5) 5
cirrhosis (5) 5
colorectal neoplasms - drug therapy (5) 5
gastroenterology and hepatology (5) 5
gene expression (5) 5
hepatology (5) 5
hospitals (5) 5
immunotherapy (5) 5
internal medicine (5) 5
materials science (5) 5
materials science, multidisciplinary (5) 5
medicine, general & internal (5) 5
medicine, research & experimental (5) 5
metastases (5) 5
models (5) 5
neoplasm metastasis (5) 5
neoplasm staging (5) 5
niacinamide - analogs & derivatives (5) 5
radioembolization (5) 5
science (5) 5
antineoplastic agents - pharmacology (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Oncology, ISSN 0923-7534, 10/2018, Volume 29, Issue suppl_7
Journal Article
Journal of Hepatology, ISSN 0168-8278, 09/2019, Volume 71, Issue 3, pp. 543 - 552
Nivolumab, an immune checkpoint inhibitor, is approved in several countries to treat sorafenib-experienced patients with HCC, based on results from the... 
Liver cancer | Nivolumab | HCC | Hepatocellular carcinoma | PD-1 inhibitor | Immuno-oncology | Asian | CheckMate | MANAGEMENT | BLOCKADE | GASTROENTEROLOGY & HEPATOLOGY | DOCETAXEL | Index Medicus
Journal Article
Cancer, ISSN 0008-543X, 11/2016, Volume 122, Issue 22, pp. 3430 - 3446
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10088, pp. 2492 - 2502
Summary Background For patients with advanced hepatocellular carcinoma, sorafenib is the only approved drug worldwide, and outcomes remain poor. We aimed to... 
Internal Medicine | CELL LUNG-CANCER | MEDICINE, GENERAL & INTERNAL | EFFICACY | SAFETY | IMMUNOTHERAPY | SORAFENIB | BLOCKADE | DOCETAXEL | PD-1 | Drug Administration Schedule | Humans | Antibodies, Monoclonal - adverse effects | Liver Neoplasms - drug therapy | Male | Response Evaluation Criteria in Solid Tumors | Treatment Outcome | Antineoplastic Agents - administration & dosage | Tumor Burden | Dose-Response Relationship, Drug | B7-H1 Antigen - metabolism | Carcinoma, Hepatocellular - drug therapy | Time Factors | Antibodies, Monoclonal - administration & dosage | Antineoplastic Agents - adverse effects | Nivolumab | Carcinoma, Hepatocellular - pathology | Biomarkers, Tumor - metabolism | Female | Liver Neoplasms - pathology | Aged | Virus diseases | Medical colleges | Care and treatment | Cell death | College teachers | Hepatoma | Comparative analysis | Drug approval | Slopes | Therapy | Pemphigoid | Intravenous administration | Inhibitor drugs | PD-1 protein | Funding | Liver | Medical services | Clinical trials | Hepatocellular carcinoma | Lymphocytes T | Infections | Metastasis | Dosage | Cancer therapies | B7 antigen | Acceptability | Incidence | Hepatitis | Liver cancer | Pathways | Quality | Immunotherapy | Safety engineering | Safety management | Safety | Expansion | Drug dosages | Liver diseases | Effectiveness | Mortality | Group dynamics | Patients | Hospitals | Inhibitors | Immune checkpoint | Adults | Solid tumors | Hepatitis C virus | Hepatitis C | Tumors | Apoptosis | Index Medicus | Abridged Index Medicus
Journal Article
Current Colorectal Cancer Reports, ISSN 1556-3790, 12/2018, Volume 14, Issue 6, pp. 192 - 198
Recent Findings Current molecular testing algorithms may need to be expanded to allow better target discovery and for patients to benefit from more therapeutic... 
Oncogenic gene fusions | Colon cancer | Rectal cancer | Targeted therapy | Immunotherapy | Microbiome | Medical research | Algorithms | Gene mutations | Colorectal cancer | Medicine, Experimental | Metastasis
Journal Article
Annals of Oncology, ISSN 0923-7534, 11/2015, Volume 26, Issue suppl 7, pp. vii121.4 - vii121
Journal Article
Journal of Geriatric Oncology, ISSN 1879-4068, 2014, Volume 5, pp. S7 - S7
Journal Article
Cancer Research, ISSN 0008-5472, 04/2012, Volume 72, Issue 8 Supplement, pp. 2314 - 2314
Journal Article
Nature Genetics, ISSN 1061-4036, 12/2013, Volume 45, Issue 12, pp. 1474 - 1478
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2014, Volume 9, Issue 3, pp. e90909 - e90909
Background: The safety and tolerability of sequential radioembolization-sorafenib therapy is unknown. An open-label, single arm, investigator-initiated Phase... 
TRIAL | SURVIVAL | HEPATIC-TUMORS | EFFICACY | MULTIDISCIPLINARY SCIENCES | TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION | RADIOTHERAPY | LIVER-DISEASE | Y-90 MICROSPHERES | CANCER | RADIATION-THERAPY | Niacinamide - analogs & derivatives | Humans | Middle Aged | Male | Embolization, Therapeutic - adverse effects | Dose-Response Relationship, Drug | Carcinoma, Hepatocellular - drug therapy | Time Factors | Phenylurea Compounds - adverse effects | Liver Neoplasms - physiopathology | Female | Yttrium Radioisotopes - therapeutic use | Carcinoma, Hepatocellular - physiopathology | Liver Neoplasms - drug therapy | Niacinamide - adverse effects | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Carcinoma, Hepatocellular - radiotherapy | Carcinoma, Hepatocellular - surgery | Liver Neoplasms - surgery | Disease Progression | Liver Neoplasms - radiotherapy | Quality of Life | Aged | Neoplasm Staging | Antimitotic agents | Care and treatment | Hepatoma | Antineoplastic agents | Liver | Therapy | Nuclear magnetic resonance--NMR | Toxicity | Hepatocellular carcinoma | Cancer therapies | Medical schools | Microspheres | Liver cancer | Quality | Hepatology | Safety | Vascular endothelial growth factor | Liver diseases | Radiation therapy | Disease control | Patients | Thrombosis | Studies | Survival analysis | Hospitals | Medical prognosis | Yttrium | Cancer | Tumors | Index Medicus | Nuclear magnetic resonance | NMR
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2018, Volume 36, Issue 3, pp. 276 - 282
Purpose No standard treatment exists for patients with cholangiocarcinoma for whom first-line gemcitabine-based therapy fails. Fibroblast growth factor... 
CRITERIA | ONCOLOGY | INHIBITOR | CANCER | INTRAHEPATIC CHOLANGIOCARCINOMAS | GENETIC ALTERATIONS | Index Medicus | ORIGINAL REPORTS
Journal Article
Clinical cancer research : an official journal of the American Association for Cancer Research, ISSN 1078-0432, 07/2018
Background The oxaliplatin plus S-1 and cisplatin plus S-1 regimens are interchangeably used in the management of advanced gastric cancer. The... 
Journal Article
ONCOLOGY, ISSN 0890-9091, 04/2008, Volume 22, Issue 4, pp. 424 - 426
Patupilone and ixabepilone have demonstrated clinical antitumor activity either alone or in combination in various cancers including ovarian, bladder,... 
Antimitotic agents | Complications and side effects | Dosage and administration | Research | Antineoplastic agents | Drug therapy | Cancer
Journal Article